malaria vaccine

An as-yet hypothetical vaccine against malaria. Development of such a vaccine is extremely difficult given Plasmodium falciparum’s high mutability, in part because it reproduces sexually within the mosquito host, thus maintaining or even increasing its heterozygosity, and because natural immunity to P falciparum requires continued contact with plasmodia to enrich the immune response to the genetically diverse agent, as opposed to the “one-shot” exposure of a vaccine.

Mentioned in

References in periodicals archive

For instance, Mosquirix (RTS,S), the first malaria vaccine developed by GlaxoSmithKline plc.

At 150.0% CAGR, Malaria Vaccines Market to Surge past US$ 790.7 Million by 2027 / Key Findings, Regional Analysis, and Key Players GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biot

Summary: A new malaria vaccine now being piloted in sub-Saharan Africa, where 90 percent of malaria cases occur, could be a game changer in global health.

Making the most of the malaria vaccine

Duque issued the statement after the Malawi government made available the world's first malaria vaccine to children up to two years of age.

DOH not yet trying new malaria vaccines

The world's first malaria vaccine for small children has been successfully piloted in Malawi.

War on malaria to get Sh62 billion

In the next few weeks, the country will roll out a malaria vaccine for children, as part of a global campaign to stop Africa's biggest killer.

Malaria vaccine offers hope

Some 360,000 children in three African countries will receive the world's first malaria vaccine as part of a large-scale pilot project, the World Health Organisation (WHO) said on Tuesday.

360,000 Children In Malawi, Kenya, Ghana To Receive World's First Malaria Vaccine

called the world's first malaria vaccine to give partial protection to

Innovative Child Malaria Vaccine to Be Tested in Malawi

GeoVax Labs, a biotechnology company developing human vaccines, has expanded its partnership with United States-based Leidos, to develop malaria vaccine candidates, it was reported yesterday.

GeoVax Labs expands Leidos collaboration

Global Banking News-February 5, 2019-VLP Therapeutics to launch first clinical trial of VLPM01 malaria vaccine at the Walter Reed Army Institute of Research

VLP Therapeutics to launch first clinical trial of VLPM01 malaria vaccine at the Walter Reed Army Institute of Research

Three countries to pilot world's first malaria vaccine

Malaria infecting 7,000 children annually in province